期刊文献+

运动负荷试验对他汀类药物相关性肌病的预测 被引量:1

Forecasting study of treadmill stress test in statin - related myopathy
下载PDF
导出
摘要 目的研究运动负荷试验对他汀类药物相关性肌病的预测作用,并探索热休克蛋白家族是否与该病发生相关。方法选取他汀药物口服适应证患者57例,签订知情同意书。运动负荷试验标准:参试者在一定条件下(心率达到最大心率的65%±5%),进行3次踏车运动,每次持续15 min,每两次运动之间休息10 min。所有参试者在未口服他汀类降脂药物及服药5 d后的运动前后以及服药10 d后分别采血,所有步骤均在清晨空腹完成。检测患者肝功能、血脂、CK、HSP25、HSP70及Cry-αB血清水平。随访服药6个月内出现不能归因于其他疾病的肌肉易疲劳、肌痛、CK升高等症状者纳入他汀类药物相关性肌病组,否则为非肌病组。使用SPSS 16.0分析肌病组与非肌病组之间数据相关性。结果肌病组服药5 d运动后的CK值比未服药运动前的CK值升高(46.08±5.61)U/L,非肌病组升高(14.98±2.44)U/L,差异具有统计学意义(P<0.05);肌病组服药5 d运动后的HSP70水平较未服药运动前升高(0.16±0.04)ng/ml,非肌病组升高(0.02±0.03)ng/ml,差异具有统计学意义(P<0.05);两组间HSP25、Cry-αB在服药前后及运动前后均无明显变化(P>0.05)。结论运动负荷试验对他汀类药物相关性肌病的发生有一定的预测作用,HSP70可能与他汀类药物相关性肌病的发生有关。 Objective To investigate the predictive function of treadmill stress test in statin - related myopathy ( SRM), and to study whether the heat shock protein family would be the predictive factors for SRM. Methods Fifty - seven patients who were eligible for statins signed informed consents. The treadmill stress test was done as follows: patients treaded at a certain condition (reach 65% ±5% of their maximum heart rate) for three 15 -minnte periods with 10 minutes of rest between exercise bouts. Before, 5 days and 10 clays after statin administration, blood sampling was done before and immediately after treadmill stress test. All the procedures were performed fasting in the morning. Then the serum levels of liver function, lipids, CK, HSP25, HSP70 and Cry - ctB in the blood sam- ples were tested. All the patients were followed up for 6 months. Patients who had the symptoms that could not be explained by other causes were divided into the SRM group, while the rest into the non - SRM group. The correlation between SRM group and non - SRM group was analysed with SPSS 16.0. Results Compared with CK before treadmill stress test without statin administration, CK after treadmill stress test with statin administration for 5 days CK increased by (46.08±5.61 ) U/L in SRM group, which was much higher than that in non- SRM group (14.98±2.44) U/L, with significant difference (P 〈 0.05 ). HSP70, after treadmill stress test with statin administration for 5 days increased by (0.16 ±0.04) ng/ml, compared with that before treadmill stress test without statin ad- ministration in SRM group, while it only increased by (0.02±0.03 ) ng/ml in non - SRM group, and the difference between the two groups was significant( P 〈 0.05 ). However, the changes in HSP 25 and Cry - αB at different time points between the two groups were not significantly diffcrent( P 〉 0.05 ). Conclusions The treadmill stress test may predict the statin - related myopathy to some extent, and HSP 70 may be associated with SRM.
出处 《武警医学》 CAS 2013年第8期655-659,共5页 Medical Journal of the Chinese People's Armed Police Force
关键词 他汀类药物相关性肌病 肌酸激酶 热休克蛋白 运动负荷试验 statin- related myopathy creatine kinase heat shock protein treadmill stress test
  • 相关文献

参考文献20

  • 1Ridker P, Danielson E, Fonseca F ,et al. JUPITER Trial Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C -reactive protein [ J ]. N Engl J Med, 2008,359 ( 21 ) : 2195 - 2207.
  • 2Sung J C, Nichol M B, Venturini F,et al. Factors af- fecting patient compliance with antihyper/ipidemic medi- cations in an HMO population [J] . Manag Care,1998, 4(10) :1421 - 1430.
  • 3Vaughan C J, Gotto A M Jr. Update on statins: 2003 [ J]. Circulation,2004,110(7) :886 - 892.
  • 4Nichols G A, Koro C E. Does statin therapy initiation in- crease the risk for myopathy An observational study of 32,225 diabetic and nondiabetic patients [ J]. Clin T- her,2007,29 (8) : 1761 - 1770.
  • 5朱天一,牛琦,张平,吴翔.他汀类药物相关肌病临床和病理学研究[J].中华全科医学,2010,8(12):1646-1647. 被引量:2
  • 6Vaklavas C, Chatzizisis Y S, Ziakas A, et al. Molecu- lar basis of statin - associated myopathy [ J ]. Athero- sclerosis, 2009,202 ( 1 ) : 18.
  • 7于瑾,马维娅,白皛,吴士文.他汀类药物相关神经肌肉病的研究进展[J].中国康复理论与实践,2009,15(1):10-12. 被引量:4
  • 8Sirvent P, Mercier J, Vassort G, et al. Simvastatin trig- gers mitochondria- induced Ca2 signaling alteration in skeletal muscle [ J ]. Biochem Biophys Res Commun, 2005, 329(3) : 1067 - 1075.
  • 9Wilhelmsen L, Link E, Parish S. SLCO1B1 variants and statin - induced myopathy - a genomewide study [J]. New Engl J ned, 2008, 359(8) : 789 -799.
  • 10Dorajoo R, Pereira B P, Zou Yu, et al. Role of multi - drug resistance - associated protein - 1 transporter in statin - induced myopathy [ J ]. Life Sci, 2008, 82 ( 15-16) : 823 -830.

二级参考文献45

  • 1Ballantyne CM, Corsini A, Davidson MH, et al. Risk for myopathy with statin therapy in high-risk patients[J]. Arch Intern Med, 2003, 163(5):553-564.
  • 2Lewis SJ, Moye I.A, Sacks FM, et al. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial[J]. Ann Intern Med, 1998, 129(9):681-689.
  • 3Sacks FM. High-intensity statin treatment for coronary heart disease [J]. JAMA, 2004, 291(9):1132-1134.
  • 4Pasternak R. ACC/AHA/NHLBI clinical advisory on the use and safety of statins[J]. Stroke, 2002, 33(9):2337-2341.
  • 5Graham DJ, Staffa JA, Shatin D, et al. Incidence of hospitalized rhabdomyolysis in patients treated with llpid-lowering drugs[J]. JAMA, 2004, 292(21):2585-2590.
  • 6Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy[J]. JAMA, 2003, 289(13):1681-1690.
  • 7Bellosta S, Paoletti R, Corsini A. Safety of statins: focus on clinical pharmacokinetics and drug interactions[JJ. Circulation, 2004, 109 (23):11150-11157.
  • 8Law M, Rudnicka AR. Statin safety: a systematic review[J]. Am J Cardiol, 2006, 97(8A):52C-60C.
  • 9Davidson MH, Ose I., Frohlich J, et al. Differential effects of simvastatin and atorvastatin on high density lipoprotein cholesterol and apolipoprotein A-1 are consistent across hypereholesterolemic patient subgroups[J]. Clin Cardiol, 2003, 26(11):509-514.
  • 10Rosenson RS. Current overview of statin induced myopathy[J]. Am J Med, 2004, 116(6) :408-416.

共引文献4

同被引文献6

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部